YU401A - Sredstva sa antidepresivnim dejstvom - Google Patents

Sredstva sa antidepresivnim dejstvom

Info

Publication number
YU401A
YU401A YU401A YU401A YU401A YU 401 A YU401 A YU 401A YU 401 A YU401 A YU 401A YU 401 A YU401 A YU 401A YU 401 A YU401 A YU 401A
Authority
YU
Yugoslavia
Prior art keywords
agents
antidepressive effect
antidepressive
effect
benzothizole
Prior art date
Application number
YU401A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
Jerzy Maj
Original Assignee
Boehringer Ingelheim Pharma Kg.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Kg. filed Critical Boehringer Ingelheim Pharma Kg.
Publication of YU401A publication Critical patent/YU401A/sh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
YU401A 1998-07-07 1999-07-02 Sredstva sa antidepresivnim dejstvom YU401A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19830201A DE19830201A1 (de) 1998-07-07 1998-07-07 Mittel mit antidepressiver Wirkung

Publications (1)

Publication Number Publication Date
YU401A true YU401A (sh) 2003-10-31

Family

ID=7873155

Family Applications (1)

Application Number Title Priority Date Filing Date
YU401A YU401A (sh) 1998-07-07 1999-07-02 Sredstva sa antidepresivnim dejstvom

Country Status (33)

Country Link
US (1) US6255329B1 (cs)
EP (1) EP1093369B1 (cs)
JP (1) JP2002520273A (cs)
KR (1) KR100557692B1 (cs)
CN (1) CN1230168C (cs)
AR (1) AR019896A1 (cs)
AT (1) ATE228365T1 (cs)
AU (1) AU762128B2 (cs)
BG (1) BG64972B1 (cs)
BR (1) BR9911768A (cs)
CA (1) CA2336833C (cs)
CZ (1) CZ294087B6 (cs)
DE (2) DE19830201A1 (cs)
DK (1) DK1093369T3 (cs)
EA (1) EA003142B1 (cs)
EE (1) EE04296B1 (cs)
ES (1) ES2183583T3 (cs)
HK (1) HK1037976A1 (cs)
HU (1) HUP0103922A3 (cs)
ID (1) ID27776A (cs)
IL (1) IL140603A0 (cs)
MY (1) MY117969A (cs)
NO (1) NO20010064L (cs)
NZ (1) NZ509729A (cs)
PL (1) PL195043B1 (cs)
PT (1) PT1093369E (cs)
RS (1) RS49795B (cs)
SK (1) SK284923B6 (cs)
TR (1) TR200100146T2 (cs)
TW (1) TW592698B (cs)
WO (1) WO2000002542A2 (cs)
YU (1) YU401A (cs)
ZA (1) ZA200100090B (cs)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000006162A1 (de) * 1998-07-27 2000-02-10 Boehringer Ingelheim Pharma Kg Mittel mit antidepressiver wirkung, mit pramipexol und einem weiteren antidepressivum
WO2002069974A1 (en) * 2001-03-05 2002-09-12 Andrew Holman Administration of sleep restorative agents
DE10138275A1 (de) * 2001-08-10 2003-02-27 Boehringer Ingelheim Pharma Verbindungen zur Beseitigung der Anhedonie
ES2432527T3 (es) * 2001-12-11 2013-12-04 University Of Virginia Patent Foundation Uso de pramipexol para tratar la esclerosis lateral amiotrófica
US20060281797A1 (en) * 2001-12-11 2006-12-14 University Of Virginia Patent Foundation Neurorestoration with R(+) Pramipexole
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
WO2005070428A1 (en) * 2004-01-22 2005-08-04 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and a dopamine agonist
WO2007022182A1 (en) * 2005-08-15 2007-02-22 University Of Virginia Patent Foundation Neurorestoration with r(+) pramipexole
US8518926B2 (en) 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
DK2026803T3 (da) 2006-05-16 2012-04-16 Knopp Neurosciences Inc Sammensætninger af R(+) og S(-) pramipexol og fremgangsmåder til anvendelse heraf
US20080254118A1 (en) * 2007-04-11 2008-10-16 Hans-Werner Wernersbach Process for preparing pramipexole dihydrochloride tablets
US8524695B2 (en) 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
AU2008224844B2 (en) 2007-03-14 2012-08-09 Knopp Neurosciences, Inc. Synthesis of chirally purified substituted benzothiazole diamines
US20080254117A1 (en) * 2007-04-10 2008-10-16 Noel Cotton Process for preparing pramipexole dihydrochloride tablets
CN102186350A (zh) * 2008-08-19 2011-09-14 诺普神经科学股份有限公司 使用(r)-普拉克索的组合物与方法
EP2341912B1 (en) 2008-09-05 2014-01-22 Supernus Pharmaceuticals, Inc. Method of treatment of attention deficit/hyperactivity disorder (adhd)
MX2011011579A (es) * 2009-04-30 2012-01-27 Supernus Pharmaceuticals Inc Metodo de tratamiento contra la depresion.
US9512096B2 (en) 2011-12-22 2016-12-06 Knopp Biosciences, LLP Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
MX356727B (es) 2012-02-08 2018-06-12 Supernus Pharmaceuticals Inc Formulaciones de liberacion modificada de viloxacina.
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
ES2858500T3 (es) 2013-07-12 2021-09-30 Knopp Biosciences Llc Tratamiento de niveles elevados de eosinófilos y/o basófilos
AU2014306683B2 (en) 2013-08-13 2017-10-12 Knopp Biosciences Llc Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders
HUE055850T2 (hu) 2013-08-13 2022-01-28 Knopp Biosciences Llc Készítmények és módszerek a krónikus urticaria (csalánkiütés) kezelésére
KR20200002899A (ko) * 2017-04-10 2020-01-08 체이스 테라퓨틱스 코포레이션 시누클레인병변을 치료하기 위한 nk1-길항제 배합물 및 방법
JP7158425B2 (ja) * 2017-06-30 2022-10-21 チェイス セラピューティクス コーポレイション Nk-1アンタゴニスト組成物およびうつ病の処置における使用法
CN110028464B (zh) * 2019-04-26 2022-11-18 浙江海洋大学 一种南极真菌次级代谢衍生物BTZ-one及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
DE3572485D1 (en) * 1984-12-22 1989-09-28 Thomae Gmbh Dr K Tetrahydro-benzothiazoles, their production and their use as intermediates or drugs
DE3843227A1 (de) * 1988-12-22 1990-07-05 Boehringer Ingelheim Kg Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
DE3937271A1 (de) * 1989-11-09 1991-05-16 Boehringer Ingelheim Kg Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
DE4241013A1 (de) * 1992-12-05 1994-06-09 Boehringer Ingelheim Kg Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung
JP3947582B2 (ja) * 1995-08-15 2007-07-25 中外製薬株式会社 不安神経症治療剤
TR199801929T2 (xx) * 1996-03-29 1998-12-21 Pfizer Inc. Benzil(iden)-laktam t�revleri, bunlar�n 5-HT1A resept�rlerinin (ant)agonistler olarak kullan�mlar� .
ES2231902T3 (es) * 1996-12-02 2005-05-16 MERCK SHARP & DOHME LTD. Uso de antagonistas del receptor de nk-1 para el tratamiento de transtornos del movimiento.
AU765522B2 (en) * 1998-01-13 2003-09-18 Synchroneuron, Llc Methods of treating tardive dyskinesia and other movement disorders

Also Published As

Publication number Publication date
KR100557692B1 (ko) 2006-03-07
ES2183583T3 (es) 2003-03-16
EA003142B1 (ru) 2003-02-27
DK1093369T3 (da) 2002-12-16
TR200100146T2 (tr) 2001-07-23
ATE228365T1 (de) 2002-12-15
EP1093369A2 (de) 2001-04-25
HUP0103922A3 (en) 2002-08-28
RS49795B (sr) 2008-06-05
IL140603A0 (en) 2002-02-10
NZ509729A (en) 2003-06-30
WO2000002542A3 (de) 2000-06-22
EE200100014A (et) 2002-06-17
SK112001A3 (en) 2001-10-08
KR20010079491A (ko) 2001-08-22
CN1230168C (zh) 2005-12-07
AU5030399A (en) 2000-02-01
SK284923B6 (sk) 2006-02-02
DE19830201A1 (de) 2000-01-13
EE04296B1 (et) 2004-06-15
AU762128B2 (en) 2003-06-19
PT1093369E (pt) 2003-03-31
JP2002520273A (ja) 2002-07-09
EP1093369B1 (de) 2002-11-27
TW592698B (en) 2004-06-21
ID27776A (id) 2001-04-26
HK1037976A1 (en) 2002-03-01
WO2000002542A2 (de) 2000-01-20
HUP0103922A2 (hu) 2002-03-28
US6255329B1 (en) 2001-07-03
BG64972B1 (bg) 2006-11-30
DE59903556D1 (de) 2003-01-09
BG105112A (en) 2001-10-31
CA2336833C (en) 2008-09-23
AR019896A1 (es) 2002-03-20
NO20010064L (no) 2001-03-02
EA200100084A1 (ru) 2001-08-27
PL195043B1 (pl) 2007-08-31
CZ294087B6 (cs) 2004-10-13
PL345842A1 (en) 2002-01-14
CN1308533A (zh) 2001-08-15
ZA200100090B (en) 2002-04-04
CA2336833A1 (en) 2000-01-20
CZ200177A3 (en) 2001-06-13
BR9911768A (pt) 2001-04-03
MY117969A (en) 2004-08-30
NO20010064D0 (no) 2001-01-05

Similar Documents

Publication Publication Date Title
YU401A (sh) Sredstva sa antidepresivnim dejstvom
CA2301899A1 (en) Agent with an antidepressant activity
BR0007527A (pt) Fenilfenantridinas com atividade inibitória depde-iv
BG106586A (en) Pyrazolopyramidines as therapeutic agents
NO20013444D0 (no) Triazolforbindelser med dopamin-D3-reseptor-affinet
TR200003004T2 (tr) Kalpain önleyicileri olarak heterosiklik ikame edilmiş amidler
BR0012752A (pt) Benzofuril piperazinas e benzofuril homopiperazinas: agonistas de serotonina
DE60112974D1 (en) Carbolinderivate
TR199901191T2 (xx) Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�.
YU19499A (sh) Benzonaftiridini kao bronhijalni terapeutici
DE59914814D1 (de) Heterozyklische substituierte amide, deren herstellung und anwendung
DE60216233D1 (en) Carbolinderivate
MXPA02010088A (es) Derivados de ecteinascidina antitumorales.
TR200003071T2 (tr) Sistein-proteazı önleyici etkiye sahip yeni heterosiklik ikame edilmiş amidler
NO20005290L (no) Riluzol- og levodopa kombinasjoner for behandling av Parkinsons sykdom
SI1086096T1 (en) Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
DK1463735T3 (da) Imidazo-2,1-B -1,3,4-thiadiazol-sulfonamider
BR9914848A (pt) Composição e processo para o tratamento de distúrbios da retina externa
BG105710A (en) 5ht1 antagonists for antidepressant therapy
YU18801A (sh) Eletriptan hidrobromid monohidrat
MXPA02007903A (es) Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres.
AU7028798A (en) Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent
IL139303A0 (en) Treatment of arthritis and other similar conditions
DE60222552D1 (de) Carbamate von 2-heterozyklischen 1,2-ethandiolen
BR0008791A (pt) Derivados anticonvulsivos, úteis no tratamento de tremor essencial